<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="ssadh" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">ssadh</book-part-id>
      <title-group>
        <title>Succinic Semialdehyde Dehydrogenase Deficiency</title>
        <alt-title alt-title-type="alt-title">Synonyms: 4-Hydroxybutyric Aciduria, Gamma-Hydroxybutyric Aciduria, SSADH Deficiency</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pearl</surname>
            <given-names>Phillip L</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Professor of Neurology, Boston Children&#x02019;s Hospital<break/>Harvard Medical School<break/>Boston, Massachusetts</aff>
          <email>phillip.pearl@childrens.harvard.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wiwattanadittakul</surname>
            <given-names>Natrujee</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Faculty of Medicine<break/>Chiang Mai University<break/>Chiang Mai, Thailand</aff>
          <email>natrujee.w@gmail.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Roullet</surname>
            <given-names>Jean-Baptiste</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Professor, College of Pharmacology<break/>Washington State University<break/>Spokane, Washington</aff>
          <email>j.roullet@wsu.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gibson</surname>
            <given-names>K Michael</given-names>
          </name>
          <degrees>PhD, FACMG</degrees>
          <aff>Professor and Head, Section of Clinical Pharmacology<break/>College of Pharmacy<break/>Washington State University<break/>Spokane, Washington</aff>
          <email>mike.gibson@wsu.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>5</day>
          <month>5</month>
          <year>2004</year>
        </date>
        <date date-type="updated">
          <day>28</day>
          <month>4</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="stickler" document-type="chapter">Stickler Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="iiae3" document-type="chapter">Susceptibility to Infection-Induced Acute Encephalopathy 3</related-object>
      <abstract id="ssadh.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Succinic semialdehyde dehydrogenase (SSADH) deficiency is characterized by infantile-onset hypotonia, developmental delay, cognitive impairment, expressive language deficit, and mild ataxia. Epilepsy is present in about half of affected individuals and is more common in adults. Hyperkinetic behavior, aggression, self-injurious behaviors, hallucinations, and sleep disturbances have been reported in nearly half of all affected individuals, more commonly in those who are older. Basal ganglia signs including choreoathetosis, dystonia, and myoclonus have been reported in a few individuals with earlier-onset, more severe disease. Involvement beyond the central nervous system has not been described.</p>
          <p>Individuals with SSADH deficiency typically have 4-hydroxybutyric aciduria present on urine organic acid analysis. Head MRI reveals T<sub>2</sub> hyperintensities in multiple regions, involving the globus pallidi, cerebellar dentate nuclei, subthalamic nuclei, subcortical white matter, and brain stem, as well as cerebral and sometimes cerebellar atrophy. EEG findings include background slowing and spike discharges that are usually generalized.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of SSADH deficiency is established by the identification of biallelic pathogenic variants in <italic toggle="yes">ALDH5A1</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Management is most often symptomatic, directed at the treatment of seizures and neurobehavioral disturbances. A broad spectrum of antiepileptic medication has been used to treat this condition. While vigabatrin is an irreversible inhibitor of GABA-transaminase and thus inhibits the formation of succinic semialdehyde, it has shown inconsistent results in treatment of seizures associated with SSADH deficiency. Methylphenidate, thioridazine, risperidal, fluoxetine, and benzodiazepines have been used for treatment of increased anxiety, aggressiveness, and inattention. Additional, non-pharmacologic treatments may include physical and occupational therapy, sensory integration, feeding and/or speech therapy.</p>
          <p><italic toggle="yes">Surveillance:</italic> Regular neurologic and developmental assessments as indicated.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Valproate may inhibit residual SSADH enzyme activity; however, valproate may be considered in individuals with refractory epilepsy who have failed other treatments.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>SSADH deficiency is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives is possible if the pathogenic variants have been identified in the family. Biochemical testing is not accurate or reliable for carrier determination. Prenatal diagnosis for pregnancies at increased risk is possible using molecular genetic testing if the pathogenic variants have been identified in the family, or using biochemical testing (either measurement of 4-hydroxybutyric acid in amniotic fluid or assay of SSADH enzyme activity in chorionic villus tissue and cultured amniocytes).</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="ssadh.Diagnosis">
        <title>Diagnosis</title>
        <sec id="ssadh.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Succinic semialdehyde dehydrogenase (SSADH) deficiency <bold>should be suspected</bold> in individuals with the following clinical, imaging, EEG, and supportive laboratory findings:</p>
          <p><bold>Clinical features.</bold> Late-infantile to early-childhood onset, slowly progressive or static encephalopathy characterized by:</p>
          <list list-type="bullet">
            <list-item>
              <p>Cognitive deficiency</p>
            </list-item>
            <list-item>
              <p>Prominent expressive language deficit</p>
            </list-item>
            <list-item>
              <p>Hypotonia</p>
            </list-item>
            <list-item>
              <p>Epilepsy</p>
            </list-item>
            <list-item>
              <p>Hyporeflexia</p>
            </list-item>
            <list-item>
              <p>Ataxia</p>
            </list-item>
          </list>
          <p>
            <bold>Neuroimaging features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Cranial MRI that demonstrates:</p>
              <list list-type="bullet">
                <list-item>
                  <p>A pallidodentatoluysian pattern [<xref ref-type="bibr" rid="ssadh.REF.pearl.2009c.184">Pearl et al 2009c</xref>], showing increased T<sub>2</sub>-weighted signal involving the globus pallidi bilaterally and symmetrically, in addition to the cerebellar dentate nuclei and subthalamic nuclei</p>
                </list-item>
                <list-item>
                  <p>T<sub>2</sub>-hyperintensities of subcortical white matter and brain stem</p>
                </list-item>
                <list-item>
                  <p>Cerebral atrophy</p>
                </list-item>
                <list-item>
                  <p>Cerebellar atrophy</p>
                </list-item>
                <list-item>
                  <p>Delayed myelination</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Magnetic resonance spectroscopy that demonstrates elevated levels of GABA and related compounds in the Glx peak (e.g., GHB [gammahydroxybutyrate, also known as 4-hydroxybutyric acid], glutamate, and homocarnosine)</p>
            </list-item>
          </list>
          <p><bold>EEG findings.</bold> Background slowing and spike discharges that are usually generalized. Note: EEG studies are normal in about one third of affected individuals.</p>
          <p>
            <bold>Supportive laboratory findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Absence of metabolic acidosis</p>
            </list-item>
            <list-item>
              <p>Urine organic acid analysis</p>
              <list list-type="bullet">
                <list-item>
                  <p>4-hydroxybutyric acid concentration of 100-1200 mmol/mol creatinine (normal: &#x0003e;0-7 mmol/mol creatinine)</p>
                </list-item>
                <list-item>
                  <p>Note: (1) Specific ion monitoring may be required for the detection of this metabolite, as its presence is sometimes obscured by a large normal urea peak on routine organic acid qualitative studies [<xref ref-type="bibr" rid="ssadh.REF.pearl.2003.1413">Pearl et al 2003</xref>]; (2) falsely elevated urinary concentrations of 4-hydroxybutyric acid (GHB) have been reported in individuals in whom the urine sample was obtained using Coloplast SpeediCath catheters, which have been found to have GHB concentrations as high as 11 mmol/L [<xref ref-type="bibr" rid="ssadh.REF.wamelink.2011.216">Wamelink et al 2011</xref>].</p>
                </list-item>
                <list-item>
                  <p>Small amounts of 4,5-dihydroxyhexanoic acid and 3-hydroxyproprionic acid and significant amounts of dicarboxylic acids may be detected. Urine organic acids can be confusing with the presence of elevated levels of d-2-hydroxyglutaric acid, but in the routine organic acid analysis this will only be reported as 2-hydroxyglutaric acid.</p>
                </list-item>
                <list-item>
                  <p>Increased glycine concentration</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Plasma amino/organic acid analysis</p>
              <list list-type="bullet">
                <list-item>
                  <p>4-hydroxybutyric acid concentration of 35-600 &#x000b5;mol/L (normal: 0-3 &#x000b5;mol/L)</p>
                </list-item>
                <list-item>
                  <p>Increased glycine concentration</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Cerebrospinal fluid (CSF) analysis</p>
              <list list-type="bullet">
                <list-item>
                  <p>4-hydroxybutyric acid concentration of 100-850 &#x000b5;mol/L (normal: 0-2 &#x000b5;mol/L)</p>
                </list-item>
                <list-item>
                  <p>A transient increase in CSF glycine concentration</p>
                </list-item>
                <list-item>
                  <p>Elevated free and total GABA and homocarnosine concentrations coupled to lowered glutamine</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Note: Newborn screening is not routinely done for this disorder at this time.</p>
        </sec>
        <sec id="ssadh.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of SSADH deficiency <bold>is established</bold> in a proband by the identification of biallelic pathogenic variants in <italic toggle="yes">ALDH5A1</italic> on molecular genetic testing (see <xref ref-type="table" rid="ssadh.T.molecular_genetic_testing_used_i">Table 1</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold> or use of a <bold>multi-gene panel</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">ALDH5A1</italic> is performed first, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">ALDH5A1</italic> and other genes of interest (see <xref ref-type="sec" rid="ssadh.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
            </list-item>
          </list>
          <table-wrap id="ssadh.T.molecular_genetic_testing_used_i" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Succinic Semialdehyde Dehydrogenase Deficiency</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">ALDH5A1</italic>
                  </td>
                  <td headers="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">97%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="ssadh.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="ssadh" object-id="ssadh.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="ssadh.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="ssadh.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="ssadh.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="ssadh.TF.1.4">
                <label>4. </label>
                <p>Sixty-two families [<xref ref-type="bibr" rid="ssadh.REF.liu.2016.441">Liu et al 2016</xref>]</p>
              </fn>
              <fn id="ssadh.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="ssadh.TF.1.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="ssadh.REF.kwok.2012.280">Kwok et al [2012]</xref> reported a novel 34-bp insertion in exon 10 that resulted in a pathogenic frameshift variant leading to a truncated SSADH protein lacking 50 amino acids in the C-terminus.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="ssadh.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="ssadh.Clinical_Description">
          <title>Clinical Description</title>
          <p>SSADH deficiency is characterized by a relatively non-progressive encephalopathy presenting with hypotonia and delayed acquisition of motor and language developmental milestones in the first two years of life. Common clinical features include intellectual disability, behavior problems, and motor dysfunction.</p>
          <p>Symptoms are first reported at a mean age of 11 months (range 0-44 months) and the mean age at diagnosis is 6.6 years (range 0-25 years) [<xref ref-type="bibr" rid="ssadh.REF.pearl.2009a.343">Pearl et al 2009a</xref>]. One study reported an adult man who was diagnosed in the sixth decade of life [<xref ref-type="bibr" rid="ssadh.REF.lapalmeremis.2015.861">Lapalme-Remis et al 2015</xref>]. Psychiatric symptoms may be the most disabling; they include sometimes prominent ADHD and even aggression in early childhood, and anxiety and obsessive-compulsive disorder in adolescence and adulthood [<xref ref-type="bibr" rid="ssadh.REF.pearl.2004.107">Pearl &#x00026; Gibson 2004</xref>, <xref ref-type="bibr" rid="ssadh.REF.knerr.2008.598">Knerr et al 2008</xref>].</p>
          <p>Affected individuals do not usually have episodic decompensation following metabolic stressors as is typical of other organic acidemias and metabolic encephalopathies, although some have been diagnosed after having unanticipated difficulty recovering from otherwise ordinary childhood illnesses. Clinical presentation with acute onset of generalized hypotonia and choreiform movement following upper-respiratory tract infection has been reported [<xref ref-type="bibr" rid="ssadh.REF.wang.2015">Wang et al 2015</xref>].</p>
          <p>Approximately 10% of affected individuals have a more severe phenotype including early-onset prominent extrapyramidal manifestations and a regressive course [<xref ref-type="bibr" rid="ssadh.REF.pearl.2005b.1051">Pearl et al 2005b</xref>].</p>
          <p><bold>Seizures.</bold> Half of affected individuals have epilepsy, usually with generalized tonic-clonic or atypical absence seizures [<xref ref-type="bibr" rid="ssadh.REF.pearl.2003.1413">Pearl et al 2003</xref>]. Epilepsy is more common in adults, and may be progressive [<xref ref-type="bibr" rid="ssadh.REF.lapalmeremis.2015.861">Lapalme-Remis et al 2015</xref>]. In one family two heterozygotes for SSADH deficiency (one parent and a sib of a proband with the disorder) had generalized spike-wave discharges, photosensitivity, and absence and myoclonic seizures [<xref ref-type="bibr" rid="ssadh.REF.dervent.2004.1417">Dervent et al 2004</xref>].</p>
          <p><bold>Sleep disorders</bold> are common and manifest either as excessive daytime somnolence or as disorders of initiating or maintaining sleep [<xref ref-type="bibr" rid="ssadh.REF.philippe.2004.564">Philippe et al 2004</xref>, <xref ref-type="bibr" rid="ssadh.REF.arnulf.2005.418">Arnulf et al 2005</xref>]. Ten affected individuals studied with overnight polysomnography and daytime multiple sleep latency testing (MLST) had prolonged REM latency (mean 272 &#x000b1; 89 min) and reduced stage REM percentage (mean 8.9%, range 0.3% - 13.8%) [<xref ref-type="bibr" rid="ssadh.REF.pearl.2009b.1645">Pearl et al 2009b</xref>]. Half of these individuals showed a decrease in daytime mean sleep latency on MSLT, indicating excessive daytime somnolence. Overall, REM sleep appears to be reduced.</p>
          <p><bold>Neuropathology</bold> from one individual with a confirmed diagnosis revealed discoloration of the globus pallidus and leptomeningeal congestion on gross pathology. On microscopic examination, hyperemia and granular perivascular calcification of the globus pallidus and superior colliculus were identified, and interpreted as consistent with chronic excitotoxic injury. There was not significant neuronal loss or gliosis of CA1 of the hippocampus, the area that would have been considered most vulnerable to epileptic or hypoxic injury in this individual, who died with a clinical diagnosis of SUDEP (sudden unexpected death in epilepsy patients) after having had escalating seizures [<xref ref-type="bibr" rid="ssadh.REF.knerr.2010.255">Knerr et al 2010</xref>]. The authors are aware of two additional affected individuals who had SUDEP [Authors, unpublished data].</p>
        </sec>
        <sec id="ssadh.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No genotype-phenotype correlations have been observed.</p>
        </sec>
        <sec id="ssadh.Prevalence">
          <title>Prevalence</title>
          <p>Approximately 450 individuals have been diagnosed with SSADH deficiency [<xref ref-type="bibr" rid="ssadh.REF.gibson.2001">Gibson &#x00026; Jakobs 2001</xref>; Gibson &#x00026; Jakobs, personal communication], but it has been estimated to occur in 1:1,000,000 individuals [KM Gibson, unpublished data].</p>
          <p>Because of the nonspecific nature of SSADH deficiency and the related difficulty in diagnosing affected individuals, the disorder may be significantly underdiagnosed. Thus, the true prevalence is unknown [<xref ref-type="bibr" rid="ssadh.REF.pearl.2003.1413">Pearl et al 2003</xref>].</p>
          <p>Parental consanguinity has been reported in approximately 40% of all published cases [<xref ref-type="bibr" rid="ssadh.REF.gibson.1997a.567">Gibson et al 1997a</xref>, <xref ref-type="bibr" rid="ssadh.REF.gibson.1997b.370">Gibson et al 1997b</xref>, <xref ref-type="bibr" rid="ssadh.REF.alessa.2000.127">Al-Essa et al 2000</xref>, <xref ref-type="bibr" rid="ssadh.REF.yal_inkaya.2000.45">Yal&#x000e7;inkaya et al 2000</xref>].</p>
        </sec>
      </sec>
      <sec id="ssadh.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those described in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">ALDH5A1</italic>.</p>
        <p>One family (3 affected individuals) with developmental delay and a small chromosome duplication involving <italic toggle="yes">ALDH5A1</italic> has been described [<xref ref-type="bibr" rid="ssadh.REF.siggberg.2011.448">Siggberg et al 2011</xref>]. Elevated SSADH enzymatic activity in the affected individuals was confirmed in cultured white blood cells and may have a negative impact on GABA metabolism, possibly leading or contributing to the phenotype (see <xref ref-type="sec" rid="ssadh.Molecular_Genetics">Molecular Genetics</xref>).</p>
      </sec>
      <sec id="ssadh.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other disorders of GABA metabolism:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>4-aminobutyrate aminotransferase (GABA-transaminase, GABA-T) deficiency</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613163">613163</ext-link>). GABA transaminase deficiency was first reported in an index sibship and an additional unrelated proband [<xref ref-type="bibr" rid="ssadh.REF.medinakauwe.1999.414">Medina-Kauwe et al 1999</xref>], and then in an infant identified using MR spectroscopy [<xref ref-type="bibr" rid="ssadh.REF.tsuji.2010.85">Tsuji et al 2010</xref>]. The phenotype is characterized by psychomotor retardation, hypotonia, hyperreflexia, lethargy, refractory seizures of neonatal or infantile onset, agenesis of the corpus callosum, and cerebellar hypoplasia. Additional cases are being recognized especially with increased use of next-generation sequencing [<xref ref-type="bibr" rid="ssadh.REF.besse.2015.417">Besse et al 2015</xref>]. Free and total GABA concentration levels are elevated in the CSF, without elevation in GHB. Biallelic pathogenic variants in <italic toggle="yes">ABAT</italic> are causative. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><bold>Homocarnosinosis</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/236130/">236130</ext-link>). Homocarnosine is a dipeptide of histidine and GABA. A single case of primary homocarnosinosis has been reported; the enzyme defect has not been conclusively proven [<xref ref-type="bibr" rid="ssadh.REF.gibson.2001">Gibson &#x00026; Jakobs 2001</xref>].</p>
          </list-item>
        </list>
        <p>SSADH deficiency cannot easily be differentiated clinically from other disorders that cause intellectual disability. Screening by urine organic acid analysis is necessary to detect SSADH deficiency.</p>
        <p>Elevated glycine can be seen in <related-object link-type="booklink" source-id="gene" document-id="nkh" document-type="chapter">glycine encephalopthy</related-object> (non-ketotic hyperglycinemia), which is distinguished from SSADH based on the absence of GHB in individuals with glycine encephalopathy.</p>
        <p>Abnormal signal bilaterally in the globus pallidus can be seen in other organic acidurias, particularly methylmalonic aciduria (see <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">Methylmalonic Acidemia</related-object>), mitochondrial disorders (see <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>), <related-object link-type="booklink" source-id="gene" document-id="pkan" document-type="chapter">pantothenate kinase-associated neurodegeneration</related-object> (PKAN), and <related-object link-type="booklink" source-id="gene" document-id="neuroferritin" document-type="chapter">neuroferritinopathy</related-object> [<xref ref-type="bibr" rid="ssadh.REF.curtis.2001.350">Curtis et al 2001</xref>].</p>
        <p>Unlike other metabolic encephalopathies and some other organic acidurias, SSADH deficiency does not usually present with metabolic stroke, megalencephaly, episodic hypoglycemia, hyperammonemia, acidosis, or intermittent decompensation [<xref ref-type="bibr" rid="ssadh.REF.pearl.2003.1413">Pearl et al 2003</xref>].</p>
      </sec>
      <sec id="ssadh.Management">
        <title>Management</title>
        <sec id="ssadh.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with succinic semialdehyde dehydrogenase (SSADH) deficiency, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neuroimaging (MRI)</p>
            </list-item>
            <list-item>
              <p>EEG</p>
            </list-item>
            <list-item>
              <p>Developmental evaluation</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="ssadh.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The management of SSADH deficiency is most often symptomatic, directed at the treatment of seizures and neurobehavioral disturbances.</p>
          <p><bold>Seizures.</bold> Antiseizure medications employed for the treatment of SSADH deficiency tend to be broad spectrum, although valproate is avoided when possible because of inhibition of potential residual enzymatic activity [<xref ref-type="bibr" rid="ssadh.REF.shinka.2003.99">Shinka et al 2003</xref>]. Vigabatrin, an irreversible inhibitor of GABA-transaminase, inhibits the formation of succinic semialdehyde [<xref ref-type="bibr" rid="ssadh.REF.matern.1996.313">Matern et al 1996</xref>]. However, vigabatrin has shown inconsistent results [<xref ref-type="bibr" rid="ssadh.REF.howells.1992.181">Howells et al 1992</xref>, <xref ref-type="bibr" rid="ssadh.REF.gropman.2003.s66">Gropman 2003</xref>], suggesting that it is not effective at inhibiting peripheral GABA-transaminase, leading to a peripheral supply of 4-hydroxybutyric acid to the brain and thus decreasing its own efficacy. Brain MRI signal changes, particularly prominent in the thalamus and basal ganglia, have been seen in infants treated with relatively high doses of vigabatrin [<xref ref-type="bibr" rid="ssadh.REF.pearl.2009c.184">Pearl et al 2009c</xref>].</p>
          <p>However, reports of uncontrolled, nonblinded trials of vigabatrin in two affected children described a decrease in plasma GHB concentrations and clinical improvement (specifically in verbal communication) in one child age eight years [<xref ref-type="bibr" rid="ssadh.REF.casarano.2012.119">Casarano et al 2012</xref>] and slow clinical improvement (although not unexpected based on natural history) in a child age 2.5 years [<xref ref-type="bibr" rid="ssadh.REF.escalera.2010.128">Escalera et al 2010</xref>].</p>
          <p><bold>Neurobehavioral symptoms.</bold> Methylphenidate, thioridazine, risperidal, fluoxetine, and benzodiazepines have been used for the treatment of increased anxiety, aggressiveness, and inattention [<xref ref-type="bibr" rid="ssadh.REF.gibson.2003.763">Gibson et al 2003</xref>].</p>
          <p>Beneficial non-pharmacologic treatments include physical therapy directed at developing strength, endurance, and balance; occupational therapy for improvement of fine motor skills, feeding, and sensory integration; and speech therapy [<xref ref-type="bibr" rid="ssadh.REF.gropman.2003.s66">Gropman 2003</xref>].</p>
        </sec>
        <sec id="ssadh.Surveillance">
          <title>Surveillance</title>
          <p>Regular neurologic and developmental assessments are indicated.</p>
        </sec>
        <sec id="ssadh.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Valproate is generally contraindicated as it may inhibit residual SSADH enzyme activity [<xref ref-type="bibr" rid="ssadh.REF.shinka.2003.99">Shinka et al 2003</xref>]. However, <xref ref-type="bibr" rid="ssadh.REF.vanadia.2013.133">Vanadia et al [2013]</xref> reported an individual with SSADH deficiency who had refractory epilepsy after possible limbic encephalitis. The refractory epilepsy was finally controlled with magnesium valproate. One year after initiation of magnesium valproate therapy, the affected individual remained seizure free and had marked behavioral improvements, including decreases in aggression, coprolalia, and non-recognition of danger. In addition, the EEG demonstrated improved background organization.</p>
        </sec>
        <sec id="ssadh.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="ssadh.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="ssadh.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Biomarkers have been studied with plans for utilization in clinical trials. Positron emission tomography (PET) with [11C]flumazenil (FMZ), a benzodiazepine receptor antagonist, showed reduced binding in cortical, basal ganglia, and cerebellar regions of interest versus controls consistent with downregulation of GABA receptors [<xref ref-type="bibr" rid="ssadh.REF.pearl.2007.43">Pearl et al 2007</xref>]. Transcranial magnetic stimulation similarly showed downregulation of GABAergic activity in affected individuals versus controls [<xref ref-type="bibr" rid="ssadh.REF.pearl.2009a.343">Pearl et al 2009a</xref>]. A single case of improvement in gait, coordination, and energy was reported as an abstract in a 30-month-old male administered 200 mg/kg/day of taurine [<xref ref-type="bibr" rid="ssadh.REF.saronwala.2008">Saronwala et al 2008</xref>]. However, an open-label study of eighteen individuals with SSADH deficiency treated with taurine did not show significant improvement in adaptive behavior scores. This study was assigned a class IV level of evidence because it did not involve a control group [<xref ref-type="bibr" rid="ssadh.REF.pearl.2014.940">Pearl et al 2014</xref>].</p>
          <p>SGS-742, a GABA-B receptor antagonist, demonstrated in the murine model a significant effect on electrocorticography when compared with topiramate [<xref ref-type="bibr" rid="ssadh.REF.pearl.2009a.343">Pearl et al 2009a</xref>]. Liver-mediated gene therapy in the mouse model did lead to reductions in GHB levels in liver, kidney, serum, and brain extracts [<xref ref-type="bibr" rid="ssadh.REF.gupta.2004.527">Gupta et al 2004</xref>]. A clinical trial of SGS-742 is currently enrolling (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link>).</p>
          <p>Recent data demonstrated that administration of rapamycin to an SSADH-deficient mouse model reduced mTOR activity, reduced the elevated numbers of mitochondria in the liver and brain (due to improved mitophagy), and normalized aberrant antioxidant levels; mTOR inhibitors such as rapamycin may lead to the treatment of many diseases, including SSADH [<xref ref-type="bibr" rid="ssadh.REF.lakhani.2014.551">Lakhani et al 2014</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="ssadh.Other">
          <title>Other</title>
          <p>Animal experiments utilizing the murine model have demonstrated partial efficacy involving the amino acid taurine, vigabatrin, and GABA<sub>B</sub> and GHB receptor inhibitors [<xref ref-type="bibr" rid="ssadh.REF.gupta.2004.527">Gupta et al 2004</xref>].</p>
          <p>A murine trial has demonstrated some efficacy of the ketogenic diet [<xref ref-type="bibr" rid="ssadh.REF.nylen.2008.449">Nylen et al 2008</xref>], although the mechanism of the observed changes (and thus the potential for success in a human trial) is unknown [<xref ref-type="bibr" rid="ssadh.REF.knerr.2008.11">Knerr &#x00026; Pearl 2008</xref>].</p>
        </sec>
      </sec>
      <sec id="ssadh.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="ssadh.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Succinic semialdehyde dehydrogenase (SSADH) deficiency is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="ssadh.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">ALDH5A1</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are typically asymptomatic. One report suggests that absence epilepsy with myoclonus and photosensitivity may be related to the heterozygous state [<xref ref-type="bibr" rid="ssadh.REF.dervent.2004.1417">Dervent et al 2004</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are typically asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with SSADH are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">ALDH5A1</italic>.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of an <italic toggle="yes">ALDH5A1</italic> pathogenic variant.</p>
        </sec>
        <sec id="ssadh.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p><bold>Molecular genetic testing.</bold> Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">ALDH5A1</italic> pathogenic variants in the family.</p>
          <p><bold>Biochemical testing.</bold> Carrier testing using biochemical testing is not accurate or reliable for carrier determination.</p>
        </sec>
        <sec id="ssadh.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="ssadh.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the <italic toggle="yes">ALDH5A1</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for SSADH deficiency are possible.</p>
          <p><bold>Biochemical testing.</bold> 4-hydroxybutyric acid can be measured accurately in amniotic fluid by means of a sensitive stable-isotope dilution gas chromatography-mass spectrometry assay method using deuterium-labeled 4-hydroxybutyric acid as the internal standard [<xref ref-type="bibr" rid="ssadh.REF.gibson.2001">Gibson &#x00026; Jakobs 2001</xref>].</p>
          <p>SSADH enzyme activity can be measured in biopsied chorionic villus tissue and cultured amniocytes.</p>
          <p><bold>Molecular genetic and biochemical testing.</bold> A combination of a metabolite analysis assay of enzyme activity with molecular genetic testing increases the accuracy of prenatal testing [<xref ref-type="bibr" rid="ssadh.REF.hogema.2001.218">Hogema et al 2001</xref>].</p>
        </sec>
      </sec>
      <sec id="ssadh.Resources">
        <title>Resources</title>
      </sec>
      <sec id="ssadh.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="ssadh.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Animal studies have shown loss of locomotor function following &#x003b3;-hydroxybutyrate (GHB) administration, reversible with inhibition of the mixed amino oxidase (MAO) system, consistent with a dopaminergic effect [<xref ref-type="bibr" rid="ssadh.REF.pearl.a">Pearl et al 2005a</xref>]. Whether the cognitive, epileptic, neurobehavioral, and gait deficits in SSADH deficiency (as well as the extrapyramidal findings in ~10% of affected individuals) are related to chronically elevated endogenous GHB levels is uncertain.</p>
          <p><xref ref-type="fig" rid="ssadh.F1">Figure 1</xref> outlines the normal SSADH GABA degradative pathway. A murine model demonstrates downregulation and decreased function of the GABA<sub>A</sub> receptor, postulating an important role for GABA (gamma-aminobutyric acid) in the pathophysiology of at least the epileptic manifestations of SSADH deficiency [<xref ref-type="bibr" rid="ssadh.REF.wu.2006.42">Wu et al 2006</xref>]. More specifically, <xref ref-type="bibr" rid="ssadh.REF.errington.2011.e19021">Errington et al [2011]</xref> found that GABA<sub>A</sub> receptor-mediated inhibitory gain of function may be a common feature in murine models of typical absence seizures.</p>
          <p>A murine model demonstrated significant cerebral and cerebellar volume loss in homozygous SSADH-deficient mutant mice while no differences in total brain volume were observed in heterozygous mice or wild type controls [<xref ref-type="bibr" rid="ssadh.REF.acosta.2010.1457">Acosta et al 2010</xref>].</p>
          <p>One case report described an individual who had early-onset SSADH with low-level glutathione (GSH), thus supporting the hypothesis of oxidative stress and mitochondrial dysfunction in SSADH deficiency that was previously described in in vitro studies [<xref ref-type="bibr" rid="ssadh.REF.niemi.2014.129">Niemi et al 2014</xref>].</p>
          <p><bold>Gene structure.</bold> The <italic toggle="yes">ALDH5A1</italic> transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000090.3">NM_000090.3</ext-link> comprises ten exons distributed over 38 kb of genomic DNA. A longer transcript variant has been described. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="ssadh" object-id="ssadh.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign variants.</bold> Of 27 novel variants identified in 48 unrelated families, six did not strongly affect enzymatic activity and were considered benign variants [<xref ref-type="bibr" rid="ssadh.REF.akaboshi.2003.442">Akaboshi et al 2003</xref>].</p>
          <p><bold>Pathogenic variants.</bold> A total of 44 pathogenic variants including missense, nonsense, and splicing errors have been identified. No hotspots were detected [<xref ref-type="bibr" rid="ssadh.REF.akaboshi.2003.442">Akaboshi et al 2003</xref>, <xref ref-type="bibr" rid="ssadh.REF.liu.2016.441">Liu et al 2016</xref>]. <xref ref-type="bibr" rid="ssadh.REF.bekri.2004.347">Bekri et al [2004]</xref> reported a 7-bp deletion in exon 10 in a family with an affected child having very low enzymatic activity and reported as having a mild but typical phenotype. <xref ref-type="bibr" rid="ssadh.REF.kwok.2012.280">Kwok et al [2012]</xref> reported a novel 34-bp insertion in exon 10 that predicted a truncated SSADH protein lacking 50 amino acids in the C-terminus. Exon deletions have also been reported [<xref ref-type="bibr" rid="ssadh.REF.akaboshi.2003.442">Akaboshi et al 2003</xref>].</p>
          <p><bold>Normal gene product.</bold> GABA is metabolized to succinic acid by the sequential action of GABA-transaminase, in which GABA is converted to succinic semialdehyde, which then, by means of the enzyme succinic semialdehyde dehydrogenase, is oxidized to succinic acid.</p>
          <p><bold>Abnormal gene product.</bold> In the absence of succinic semialdehyde dehydrogenase, the transamination of GABA to succinic semialdehyde is quite likely followed by its reduction to GHB (gamma-hydroxybutyrate, a short monocarboxylic fatty acid whose role is unclear [<xref ref-type="bibr" rid="ssadh.REF.gupta.2003.s81">Gupta et al 2003</xref>]. GHB, which accumulates in the urine, serum, and CSF of individuals with SSADH deficiency, has historically been considered the neurotoxic agent most responsible for the clinical manifestations of the disease [<xref ref-type="bibr" rid="ssadh.REF.pearl.a">Pearl et al 2005a</xref>]. However, receptor studies in SSADH-deficient mice have shown alterations of GABA<sub>A</sub> and GABA<sub>B</sub> receptors but no alterations in GHB receptor binding or number, suggesting that the role of primary neurotoxin may be fulfilled by GABA [<xref ref-type="bibr" rid="ssadh.REF.vogel.2013.401">Vogel et al 2013</xref>].</p>
          <p><xref ref-type="bibr" rid="ssadh.REF.siggberg.2011.448">Siggberg et al [2011]</xref> reported a family with developmental delay segregating a duplication of 6p22.2 that included <italic toggle="yes">ALDH5A1</italic>. SSADH enzyme studies in cultured white cells revealed elevated SSADH activity, consistent with duplication as well as increased urinary SSA associated with oxidative stress. Hyperactive levels of SSADH activity may also have negative consequences for GABA metabolism and other metabolic sequences.</p>
          <p>The main function of GHB in the central nervous system is the inhibition of presynaptic dopamine release. It is currently used to induce a model of absence in rodents and to control cateplexy and alcohol withdrawal syndromes; GHB is also a recreationally abused drug.</p>
        </sec>
      </sec>
      <sec id="ssadh.References">
        <title>References</title>
        <sec id="ssadh.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="ssadh.Literature_Cited.reflist0">
            <ref id="ssadh.REF.acosta.2010.1457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Acosta</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munasinghe</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finegersh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodore</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Cerebellar atrophy in human and murine succinic semialdehyde dehydrogenase deficiency.</article-title>
                <source>J Child Neuro<italic toggle="yes">l.</italic></source>
                <volume>25</volume>
                <fpage>1457</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">20445195</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.akaboshi.2003.442">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Akaboshi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogema</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novelletto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malaspina</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomons</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maropoulos</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency.</article-title>
                <source>Hum Mutat</source>
                <volume>22</volume>
                <fpage>442</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">14635103</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.alessa.2000.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Essa</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakheet</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patay</surname>
                    <given-names>ZJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powe</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozand</surname>
                    <given-names>PT</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease.</article-title>
                <source>Brain Dev</source>
                <volume>22</volume>
                <fpage>127</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">10722966</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.arnulf.2005.418">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arnulf</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konofal</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beauvais</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Derenne</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philippe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Effect of genetically caused excess of brain gamma-hydroxybutyric acid and GABA on sleep.</article-title>
                <source>Sleep</source>
                <volume>28</volume>
                <fpage>418</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">16171286</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.bekri.2004.347">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bekri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fossoud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plaza</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guenne</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomons</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Obberghen</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The molecular basis of succinic semialdehyde dehydrogenase deficiency in one family.</article-title>
                <source>Mol Genet Metab</source>
                <volume>81</volume>
                <fpage>347</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15059623</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.besse.2015.417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Besse</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donti</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craigen</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moretti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnen</surname>
                    <given-names>PE</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>The GABA Transaminase, ABAT, is essential for mitochondrial nucleoside metabolism.</article-title>
                <source>Cell Metab.</source>
                <volume>21</volume>
                <fpage>417</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">25738457</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.casarano.2012.119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Casarano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alessandr&#x000ec;</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomons</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moretti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cioni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battini</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Efficacy of vigabatrin intervention in a mild phenotypic expression of succinic semialdehyde dehydrogenase deficiency.</article-title>
                <source>JIMD Rep.</source>
                <year>2012</year>
                <volume>2</volume>
                <fpage>119</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">23430864</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.curtis.2001.350">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Curtis</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fey</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bindoff</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ince</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coulthard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McHale</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hay</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barker</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markham</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bates</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curtis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burn</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>350</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11438811</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.dervent.2004.1417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dervent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomons</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yal&#x000e7;inkaya</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Photosensitive absence epilepsy with myoclonias and heterozygosity for succinic semialdehyde dehydrogenase (SSADH) deficiency.</article-title>
                <source>Clin Neurophysiol</source>
                <volume>115</volume>
                <fpage>1417</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">15134710</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.errington.2011.e19021">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Errington</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crunelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cope</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Aberrant GABA(A) receptor-mediated inhibition in cortico-thalamic networks of succinic semialdehyde dehydrogenase deficient mice.</article-title>
                <source>PLoS One.</source>
                <volume>6</volume>
                <fpage>e19021</fpage>
                <pub-id pub-id-type="pmid">21526163</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.escalera.2010.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Escalera</surname>
                    <given-names>GI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marina</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sala</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomons</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Succinic semialdehyde dehydrogenase deficiency: decrease in 4-OH-butyric acid levels with low doses of vigabatrin.</article-title>
                <source>An Pediatr (Barc)</source>
                <year>2010</year>
                <volume>72</volume>
                <fpage>128</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">20018576</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.gibson.1997a.567">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammersen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raab</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobori</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moosa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vollmer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iafolla</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matern</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brouwer</surname>
                    <given-names>OF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finkelstein</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aksu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakkeren</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabreels</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bluestone</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barron</surname>
                    <given-names>TF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beauvais</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehnert</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients.</article-title>
                <source>Pediatrics.</source>
                <year>1997a</year>
                <volume>99</volume>
                <fpage>567</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">9093300</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.gibson.1997b.370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doskey</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morlat</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1997b</year>
                <article-title>Differing clinical presentation of succinic semialdehyde dehydrogenase deficiency in adolescent siblings from Lifu Island, New Caledonia.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>20</volume>
                <fpage>370</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9266358</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.gibson.2003.763">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuchman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezina</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snead</surname>
                    <given-names>OC</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Smit</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).</article-title>
                <source>Biol Psychiatry</source>
                <volume>54</volume>
                <fpage>763</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14512218</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.gibson.2001">
              <mixed-citation publication-type="book">Gibson KM, Jakobs C. Disorders of beta- and alpha-amino acids in free and peptide-linked forms. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease.</italic> 8 ed. New York, NY: McGraw-Hill; 2001:2079-105.</mixed-citation>
            </ref>
            <ref id="ssadh.REF.gropman.2003.s66">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gropman</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.</article-title>
                <source>Ann Neurol</source>
                <volume>54</volume>
                <supplement>Suppl 6</supplement>
                <fpage>S66</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">12891656</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.gupta.2003.s81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogema</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottiglieri</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Concas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biggio</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sogliano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigamonti</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snead</surname>
                    <given-names>OC</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Murine succinate semialdehyde dehydrogenase deficiency.</article-title>
                <source>Ann Neurol</source>
                <volume>54</volume>
                <fpage>S81</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">12891658</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.gupta.2004.527">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senephansiri</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snead</surname>
                    <given-names>OC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Liver-directed adenoviral gene transfer in murine succinate semialdehyde dehydrogenase deficiency.</article-title>
                <source>Mol Ther</source>
                <volume>9</volume>
                <fpage>527</fpage>
                <lpage>39</lpage>
                <pub-id pub-id-type="pmid">15093183</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.hogema.2001.218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hogema</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akaboshi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomons</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schutgens</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcken</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Worthington</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maropoulos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency: increased accuracy employing DNA, enzyme, and metabolite analyses.</article-title>
                <source>Mol Genet Metab</source>
                <volume>72</volume>
                <fpage>218</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">11243727</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.howells.1992.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howells</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kok</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wrennall</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>GN</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Vigabatrin therapy in succinic semialdehyde dehydrogenase deficiency.</article-title>
                <source>Mol Neuropharmacol</source>
                <volume>2</volume>
                <fpage>181</fpage>
                <lpage>4</lpage>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.knerr.2008.598">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Knerr</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Neuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients.</article-title>
                <source>CNS Spectr</source>
                <volume>13</volume>
                <fpage>598</fpage>
                <lpage>605</lpage>
                <pub-id pub-id-type="pmid">18622364</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.knerr.2010.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Knerr</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murdoch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomons</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pope</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Combs</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Neuropathology in succinic semialdehyde dehydrogenase deficiency.</article-title>
                <source>Pediatr Neurol</source>
                <volume>42</volume>
                <fpage>255</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20304328</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.knerr.2008.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Knerr</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Ketogenic diet: stoking energy stores and still posing questions.</article-title>
                <source>Exp Neurol.</source>
                <volume>211</volume>
                <fpage>11</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18374334</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.kwok.2012.280">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kwok</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuen</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Law</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cherk</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuen</surname>
                    <given-names>YP</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A novel aldh5a1 mutation in a patient with succinic semialdehyde dehydrogenase deficiency.</article-title>
                <source>Pathology.</source>
                <volume>44</volume>
                <fpage>280</fpage>
                <lpage>282</lpage>
                <pub-id pub-id-type="pmid">22437753</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.lakhani.2014.551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lakhani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Till</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burnett</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Subramani</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Defects in GABA metabolism affect selective autophagy pathways and are alleviated by mTOR inhibition.</article-title>
                <source>EMBO Mol Med</source>
                <volume>6</volume>
                <fpage>551</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">24578415</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.lapalmeremis.2015.861">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lapalme-Remis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Meulemeester</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakraborty</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guberman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomons</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali-Ridha</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parviz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <article-title>Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood.</article-title>
                <source>Neurology.</source>
                <year>2015</year>
                <volume>85</volume>
                <fpage>861</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">26268900</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.liu.2016.441">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>XD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kan</surname>
                    <given-names>QC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>QH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhuo</surname>
                    <given-names>ZH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bai</surname>
                    <given-names>QL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Mutation analysis and prenatal diagnosis in a Chinese family with succinic semialdehyde dehydrogenase and a systematic review of the literature of reported ALDH5A1 mutations.</article-title>
                <source>J Perinat Med.</source>
                <year>2016</year>
                <volume>44</volume>
                <fpage>441</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">25431891</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.matern.1996.313">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matern</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehnert</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korinthenberg</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Seizures in a boy with succinic semialdehyde dehydrogenase deficiency treated with vigabatrin (gamma-vinyl-GABA).</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>19</volume>
                <fpage>313</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8803774</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.medinakauwe.1999.414">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Medina-Kauwe</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tobin</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Meirleir</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nyhan</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>4-Aminobutyrate aminotransferase (GABA-transaminase) deficiency.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>22</volume>
                <fpage>414</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">10407778</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.niemi.2014.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Niemi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowan</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Evidence of redox imbalance in a patient with succinic semialdehyde dehydrogenase deficiency.</article-title>
                <source>Molecular Genetics and Metabolism Reports</source>
                <volume>1</volume>
                <fpage>129</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">27896081</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.nylen.2008.449">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nylen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velazquez</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Likhodii</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cortez</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leshchenko</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adeli</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burnham</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snead</surname>
                    <given-names>OC</given-names>
                    <suffix>3rd</suffix>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype.</article-title>
                <source>Exp Neurol</source>
                <volume>210</volume>
                <fpage>449</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">18199435</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.pearl.a">
              <mixed-citation publication-type="book">Pearl PL, Acosta MT, Wallis DD, Bottiglieri T, Miotto K, Jakobs C, Gibson KM. Dyskinetic features of succinate semialdehyde dehydrogenase deficiency, a GABA degradative defect. In: Fern&#x000e1;ndez-Alvarez E, Arzimanoglou A, Tolosa E, eds. <italic toggle="yes">Paediatric Movement Disorders: Progress in Understanding.</italic> Surrey, UK: John Libbey Eurotext; 2005a:203-12.</mixed-citation>
            </ref>
            <ref id="ssadh.REF.pearl.2005b.1051">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capp</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novotny</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>2005b</year>
                <article-title>Inherited disorders of neurotransmitters in children and adults.</article-title>
                <source>Clin Biochem</source>
                <volume>38</volume>
                <fpage>1051</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16298354</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.pearl.2004.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Clinical aspects of the disorders of GABA metabolism in children.</article-title>
                <source>Curr Opin Neurol</source>
                <volume>17</volume>
                <fpage>107</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">15021235</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.pearl.2009a.343">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cortez</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter Snead</surname>
                    <given-names>O</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Knerr</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forester</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pettiford</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodore</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <article-title>Succinic semialdehyde dehydrogenase deficiency: lessons from mice and men.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2009a</year>
                <volume>32</volume>
                <fpage>343</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">19172412</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.pearl.2003.1413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acosta</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezina</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodore</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogawski</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novotny</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gropman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conry</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuchman</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Clinical spectrum of succinic semialdehyde dehydrogenase deficiency.</article-title>
                <source>Neurology.</source>
                <year>2003</year>
                <volume>60</volume>
                <fpage>1413</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12743223</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.pearl.2014.940">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schreiber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodore</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCarter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrios</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiggs</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <article-title>Taurine trial in succinic semialdehyde dehydrogenase deficiency and elevated CNS GABA.</article-title>
                <source>Neurology.</source>
                <year>2014</year>
                <volume>82</volume>
                <fpage>940</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">24523482</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.pearl.2009b.1645">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shamim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodore</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forester</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Combs</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dustin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reeves-Tyer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2009b</year>
                <article-title>Polysomnographic abnormalities in succinic semialdehyde dehydrogenase (SSADH) deficiency.</article-title>
                <source>Sleep</source>
                <volume>32</volume>
                <fpage>1645</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20041601</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.pearl.2007.43">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trzcinski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sokohl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dustin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reeves-Tyer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herscovitch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liew</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shamim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quezado</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodore</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>11C-Flumazenil PET imaging in patients with SSADH deficiency.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>30</volume>
                <supplement>Suppl 1</supplement>
                <fpage>43</fpage>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.pearl.2009c.184">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezina</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saneto</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCarter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molloy-Wells</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heffron</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trzcinski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McClintock</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conry</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elling</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodkin</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sotero de Menezes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilles</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kadom</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaillard</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2009c</year>
                <article-title>Cerebral MRI abnormalities associated with vigabatrin therapy.</article-title>
                <source>Epilepsia</source>
                <volume>50</volume>
                <fpage>184</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">18783433</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.philippe.2004.564">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Philippe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deron</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genevieve</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Neurodevelopmental pattern of succinic semialdehyde dehydrogenase deficiency (gamma-hydroxybutyric aciduria).</article-title>
                <source>Dev Med Child Neurol</source>
                <volume>46</volume>
                <fpage>564</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15287248</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.saronwala.2008">
              <mixed-citation publication-type="book">Saronwala A, Tournay A, Gargus, JJ. Taurine treatment of succinate semialdehyde dehydrogenase (SSADH) deficiency reverses MRI-documented globus lesion and clinical syndrome. Proc Am Coll Med Genet. 2008. Abstract.</mixed-citation>
            </ref>
            <ref id="ssadh.REF.shinka.2003.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shinka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohfu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhara</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Effect of valproic acid on the urinary metabolic profile of a patient with succinic semialdehyde dehydrogenase deficiency.</article-title>
                <source>J Chromatogr B Analyt Technol Biomed Life Sci</source>
                <volume>792</volume>
                <fpage>99</fpage>
                <lpage>106</lpage>
                <pub-id pub-id-type="pmid">12829002</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.siggberg.2011.448">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Siggberg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mustonen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuit</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomons</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ignatius</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knuutila</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Familial 6p22.2 duplication associates with mild developmental delay and increased SSADH activity.</article-title>
                <source>Am J Med Genet B Neuropsychiatr Genet.</source>
                <volume>156B</volume>
                <fpage>448</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">21438145</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.tsuji.2010.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aida</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomiyasu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furuya</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurosawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Errami</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomons</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osaka</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A new case of GABA transaminase deficiency facilitated by proton MR spectroscopy.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>33</volume>
                <fpage>85</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">20052547</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.vanadia.2013.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanadia</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trapolino</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanadia</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Therapeutic efficacy of magnesium valproate in succinic semialdehyde dehydrogenase deficiency.</article-title>
                <source>JIMD Rep.</source>
                <volume>8</volume>
                <fpage>133</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23430529</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.vogel.2013.401">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearl</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodore</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCarter</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <article-title>Thirty years beyond discovery--clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2013</year>
                <volume>36</volume>
                <fpage>401</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">22739941</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.wamelink.2011.216">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wamelink</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulder</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>4-Hydroxybutyric aciduria associated with catheter usage: a diagnostic pitfall in the identification of SSADH deficiency.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2011</year>
                <volume>102</volume>
                <fpage>216</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20965758</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.wang.2015">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barker</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>DD</given-names>
                  </name>
                </person-group>
                <article-title>A case of acute onset succinic semialdehyde dehydrogenase deficiency: neuroimaging findings and literature review.</article-title>
                <source>Childs Nerv Syst.</source>
                <year>2015</year>
                <month>Oct</month>
                <day>24</day>
                <pub-id pub-id-type="pmid">26499347</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.wu.2006.42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buzzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frantseva</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velazquez</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cortez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snead</surname>
                    <given-names>OC</given-names>
                    <suffix>3rd</suffix>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanisms.</article-title>
                <source>Ann Neurol</source>
                <volume>59</volume>
                <fpage>42</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16240371</pub-id>
              </element-citation>
            </ref>
            <ref id="ssadh.REF.yal_inkaya.2000.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yal&#x000e7;inkaya</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000fc;nd&#x000fc;z</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko&#x000e7;er</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fi&#x000e7;icio&#x0011f;lu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000fc;&#x000e7;&#x000fc;kercan</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>MRI findings in succinic semialdehyde dehydrogenase deficiency.</article-title>
                <source>Neuropediatrics</source>
                <volume>31</volume>
                <fpage>45</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10774997</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="ssadh.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="ssadh.Author_History">
          <title>Author History</title>
          <p>Emily S Barrios; Children&#x02019;s National Medical Center (2013-2016)Jessica L Cabalza; George Washington University (2006-2010) Philip K Capp; George Washington University (2004-2006)
Adrianne M Dorsey; Children&#x02019;s National Medical Center (2013-2016)Ian Drillings; Children&#x02019;s National Medical Center (2010-2013)Maciej Gasior, MD, PhD; National Institutes of Health (2004-2006)
K Michael Gibson, PhD, FACMG (2004-present) Thomas R Hartka, MS; George Washington University (2006-2010) Phillip L Pearl, MD (2004-present) Tom Reehal; Sheffield University (2010-2013)Jean-Baptiste Roullet, PhD (2016-present)Emily Robbins; George Washington University (2004-2006) Natrujee Wiwattanadittakul, MD (2016-present)</p>
        </sec>
        <sec id="ssadh.Acknowledgments">
          <title>Acknowledgments</title>
          <p>Supported in part by the NIH (NS 82286, NS 85369), Pediatric Neurotransmitter Diseases Association, March of Dimes National Birth Defects Foundation, and Partnership for Pediatric Epilepsy Research, including American Epilepsy Society, Epilepsy Foundation, Anna and Jim Fantaci, Fight Against Childhood Epilepsy and Seizures (FACES), Neurotherapy Ventures Charitable Research Fund, and Parents Against Childhood Epilepsy (PACE)</p>
        </sec>
        <sec id="ssadh.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>28 April 2016 (ma) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 September 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>5 October 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>25 July 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>5 May 2004 (ca) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>16 September 2003 (pp) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="ssadh.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>In the absence of SSADH, transamination of &#x003b3;-aminobutyric acid (GABA) to succinic semialdehyde is followed by reduction to 4-hydroxybutyric acid (&#x003b3;-hydroxybutyrate [GHB]). SSADH deficiency leads to significant accumulation of GHB and GABA.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ssadh-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
